Literature DB >> 19684884

Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy.

Dominik R Weiss, Gerd Juchem, Bernhard M Kemkes, Brigitte Gansera, Stephan Nees.   

Abstract

The objective of this study was to gain deeper insight into the early reasons for saphenous vein graft disease and to find a practical approach to obviate it. Intraoperative storage of freshly explanted venous grafts (45 min, 20 degrees C; n=25 in each case) in saline, saline + 5% albumin, or HTK-solution and also in heparinized autologous blood was poorly tolerated by the endothelium. Large endothelial areas (mostly >75% of total surface) were detached already during brief non-pulsatile flushing just before the transplantation. Contact of deendothelialized areas in graft remnants with defined mixtures of coagulation factors or blood (n=11-17) caused rapid coagulatory processes via expression of tissue factor and assembly of prothrombinase in the subendothelium. Attached platelets and leukocytes accelerated the procoagulatory processes further, and endothelium-dependent anticoagulatory activities were significantly abolished. During pulsatile arterial flow, the resulting blood clots exacerbated the damage of the intima markedly, because they were flushed away tearing off further endothelium. In contrast, storage of venous grafts in a plasma preparation freed from isoagglutinins and coagulation factors preserved the endothelium, which resisted arterial flow and revealed anticoagulatory activity in the presence of antithrombin III and/or protein C. We conclude that gentle preparation and preservation of the vascular endothelium with a suitable storage solution during bypass surgery is a decisive first step to obviate saphenous vein graft disease.

Entities:  

Keywords:  CABG; Saphenous vein graft disease; atherosclerosis; bypass operation; endothelium; percutaneous intervention; pericyte; subendothelium; thrombosis; tissue factor; vulnerable plaque

Year:  2009        PMID: 19684884      PMCID: PMC2719701     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  77 in total

Review 1.  Phylogenetic and functional relationships between coagulation and the innate immune response.

Authors:  S M Opal
Journal:  Crit Care Med       Date:  2000-09       Impact factor: 7.598

2.  Obligatory role of lipid mediators in platelet-neutrophil adhesion.

Authors:  Stefan Chlopicki; Magdalena Lomnicka; Richard J Gryglewski
Journal:  Thromb Res       Date:  2003-06-15       Impact factor: 3.944

Review 3.  Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries.

Authors:  J L Cox; D A Chiasson; A I Gotlieb
Journal:  Prog Cardiovasc Dis       Date:  1991 Jul-Aug       Impact factor: 8.194

Review 4.  Platelets: physiology and biochemistry.

Authors:  Kerstin Jurk; Beate E Kehrel
Journal:  Semin Thromb Hemost       Date:  2005       Impact factor: 4.180

Review 5.  Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress.

Authors:  M Gouverneur; B Berg; M Nieuwdorp; E Stroes; H Vink
Journal:  J Intern Med       Date:  2006-04       Impact factor: 8.989

Review 6.  In vivo (animal) models of vein graft disease.

Authors:  Thomas Schachner; Günther Laufer; Johannes Bonatti
Journal:  Eur J Cardiothorac Surg       Date:  2006-07-25       Impact factor: 4.191

Review 7.  Arterial endothelium and atherothrombogenesis. I--Intact endothelium in vascular and blood homeostasis.

Authors:  J Martins e Silva; Carlota Saldanha
Journal:  Rev Port Cardiol       Date:  2006-11       Impact factor: 1.374

8.  Continuous subendothelial network formed by pericyte-like cells in human vascular bed.

Authors:  E R Andreeva; I M Pugach; D Gordon; A N Orekhov
Journal:  Tissue Cell       Date:  1998-02       Impact factor: 2.466

9.  Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability.

Authors:  Matthias Jacob; Dirk Bruegger; Markus Rehm; Ulrich Welsch; Peter Conzen; Bernhard F Becker
Journal:  Anesthesiology       Date:  2006-06       Impact factor: 7.892

10.  Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces.

Authors:  D T Le; S I Rapaport; L V Rao
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

View more
  8 in total

Review 1.  Storage of saphenous vein grafts prior to coronary artery bypass grafting: is autologous whole blood more effective than saline in preserving graft function?

Authors:  Maria Tsakok; Sarah Montgomery-Taylor; Teresa Tsakok
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-29

2.  Search for optimized conditions for sealing and storage of bypass vessels: influence of preservation solution and filling pressure on the degree of endothelialization.

Authors:  Dominik Roger Weiss; Gerd Juchem; Markus Eblenkamp; Bernhard Michael Kemkes; Brigitte Gansera; Michael Geier; Stephan Nees
Journal:  Int J Clin Exp Med       Date:  2010-01-01

3.  Dynamic adhesion of umbilical cord blood endothelial progenitor cells under laminar shear stress.

Authors:  Mathew G Angelos; Melissa A Brown; Lisa L Satterwhite; Vrad W Levering; Natan T Shaked; George A Truskey
Journal:  Biophys J       Date:  2010-12-01       Impact factor: 4.033

Review 4.  Focus on cardiac pericytes.

Authors:  Stephan Nees; Dominik R Weiss; Gerd Juchem
Journal:  Pflugers Arch       Date:  2013-02-27       Impact factor: 3.657

5.  DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial.

Authors:  Walid Ben Ali; Pierre Voisine; Peter Skov Olsen; Hugues Jeanmart; Nicolas Noiseux; Tracy Goeken; Vilas Satishchandran; Filippo Cademartiri; Garry Cutter; Dave Veerasingam; Craig Brown; Maximilian Y Emmert; Louis P Perrault
Journal:  Open Heart       Date:  2018-04-13

6.  Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial.

Authors:  Ralf E Harskamp; John H Alexander; Phillip J Schulte; Colleen M Brophy; Michael J Mack; Eric D Peterson; Judson B Williams; C Michael Gibson; Robert M Califf; Nicholas T Kouchoukos; Robert A Harrington; T Bruce Ferguson; Renato D Lopes
Journal:  JAMA Surg       Date:  2014-08       Impact factor: 14.766

7.  A novel endothelial damage inhibitor for the treatment of vascular conduits in coronary artery bypass grafting: protocol and rationale for the European, multicentre, prospective, observational DuraGraft registry.

Authors:  Etem Caliskan; Sigrid Sandner; Martin Misfeld; Jose Aramendi; Sacha P Salzberg; Yeong-Hoon Choi; Vilas Satishchandran; Geeta Iyer; Louis P Perrault; Andreas Böning; Maximilian Y Emmert
Journal:  J Cardiothorac Surg       Date:  2019-10-15       Impact factor: 1.637

Review 8.  The Role of Immunomodulation in Vein Graft Remodeling and Failure.

Authors:  Fabiana Baganha; Alwin de Jong; J Wouter Jukema; Paul H A Quax; Margreet R de Vries
Journal:  J Cardiovasc Transl Res       Date:  2020-06-16       Impact factor: 4.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.